Extracellular vesicles (EVs) have been associated with a wide range of conditions including cancer metastasis, blood disorders, cardiovascular disease, infectious disease, and others. Their therapeutic potential as a cell-free treatment for cancer and other pathologies has also been extensively investigated. The inclusion of flow cytometry assays for small particle research enhances current detection methods, with the capability to analyze individual particles in significant numbers, as well as measure surface protein levels.
In our webinar we will explain how to resolve small particles, using beads and cell-derived EVs. You will also get insights into the unique technology of the NovoCyte Penteon instrument combining sensitive proprietary silicone photomultipliers, 24-bit ADCs for excellent particle separation without gain adjustments, and a fluidic system based on microfluidic technology to precisely determine cell number and concentration.